The authors apologise that a number of numerical values within The section Factors associated with the COVID-19 fear and in table 2 were incorrect.
The correct section and tables are below:
Table 2 presents the adjusted association between COVID-19 fear with demographic and healthcare characteristics. In the adjusted regression model, gender, age, occupation, residence, physical activity, smoking, DDS score, limited self-care practice, unaffordable medicine, medicine shortage, a close friend or family member diagnosed with COVID-19, and financial problem during COVID-19 were significantly associated with fear (FCV-19S). Females had approximately 4 times more fear of COVID-19 compared to males (OR = 3.83, 95% CI: 1.83–6.38), whereas ages between 50 and 64 years and above 65 years also showed 1.28 times and 1.51 times more fear than their counterparts (OR = 1.28, 95% CI: 1.12–2.46; OR: 1.51, 95% CI: 1.09–3.16). Regarding occupation, unemployed patients, and nonmanual workers were 2.47 times and 2.31 times (OR: 2.47, 95% CI: 1.76–4.17); OR: 2.31, 95% CI: 1.82–4.54) more fearful compared to the manual worker. It is also observed that patients residing in urban areas were 2.51 times (OR: 2.51, 95% CI: 1.24–4.16) more likely to fear compared with peers residing in rural areas. Moreover, type-2 diabetes patients undertaking a recommended level of MVPA (more than thrice to every day) had 0.66 times (OR: 0.66, 95% CI: 0.34–0.82) lower chances of being fear compared with peers performing less than the recommended level of physical activity. Additionally, the odds of being fear was 3.34 times (OR: 3.34, 95% CI: 1.42–5.32) and 1.21 times (OR: 1.21, 95% CI: 1.13–1.95) higher among current smoker and had low DDS, respectively, compared with their nonsmoker and high DDS counterparts. Again, those who had anxiety and comorbidity were 1.66 times and 1.43 times more likely to fear as compared to their counterparts (OR 1.66, CI: 1.27–3.53; OR 1.43, CI: 1.19–2.24). On the other hand, those who had limited self-care practice and unaffordable medicine were 3.49 times and 1.13 times higher odds (OR 3.49, CI: 1.27–5.76; OR 1.13, CI: 1.03–1.92) of being fear as compared to those peers. Lastly, we found type-2 diabetes patients who had medicine shortages, a close friend or family member diagnosed with COVID-19, and financial problems during COVID-19 were almost 2.27 times, 3.83 times, and 2.92 times higher risk of being fear as compared to their peers (OR: 2.27, CI: 1.24–4.16; OR: 3.83, CI: 1.42–6.35; OR: 2.92, CI: 1.54–4.58), respectively.
Table 2. Association between COVID-19 fear with demographic and healthcare characteristics
BDT, Bangladeshi taka; BMI, body mass index; DDS, dietary diversity score; MVPA, moderate to vigorous physical activity; OR, odds ratios
The article has been updated.
Open access
